Enanta Pharmaceuticals Inc

NASDAQ:ENTA   1:11:26 PM EDT
41.13
-0.45 (-1.08%)
Earnings Announcements

Enanta Pharmaceuticals Reports Financial Results For Fiscal Fourth Quarter And Full Year

Published: 11/21/2022 21:15 GMT
Enanta Pharmaceuticals Inc (ENTA) - Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Fourth Quarter and Year Ended September 30, 2022 With Webcast and Conference Call Today at 4:30 Pm Et.
Total Revenue of $20.3 Million for Three Months Ended September 30, 2022.
Qtrly Loss per Share $1.27.
Cash, Cash Equivalents and Marketable Securities Totaled $278.5 Million at September 30, 2022.
Q4 Earnings per Share View $-1.35, Revenue View $22.9 Million -- Refinitiv Ibes Data (analyst estimates).
Enanta -sees Cash Runway to Be Sufficient to Meet Anticipated Cash Requirements of Existing Business & Development Programs Into Q4 of Fiscal 2024.
Revenue is expected to be $20.33 Million
Adjusted EPS is expected to be -$1.60

Next Quarter Revenue Guidance is expected to be $18.52 Million
Next Quarter EPS Guidance is expected to be -$1.94

More details on our Analysts Page.